Maryland Hospital False Test Results Prompt Hill Inquiry; FDA, CMS Respond
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to inspect Adaltis, Inc.'s Italian manufacturing facilities in "late June or early July," following a Congressional hearing May 18 related to reports of faulty test results from the firm's Labotech analyzer at a Maryland hospital
You may also be interested in...
Pathologists Aim For Better Communication Following Faulty Lab Test Results
CMS will convene a meeting of medical facility accreditation organizations and government oversight bodies to address the need for improved communication between inspectors, according to College of American Pathologists President Mary Kass
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.